IP Verse

Samsung Bioepis patent opposition analysis

Get complete Patent Opposition Report for Samsung Bioepis

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Latest oppositions filed by Samsung Bioepis

Explore patent oppositions filed by Samsung Bioepis against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP3167888Treatment Of Paroxysmal Nocturnal Hemoglobinuria Patients By An Inhibitor Of ComplementALEXION PHARMACEUTICALSMay 2, 2024
EP3883606Safe And Effective Method Of Treating Ulcerative Colitis With Anti-Il12/Il23 AntibodyJANSSEN BIOTECHFeb 5, 2024
EP2894165Methods And Compositions For Treating Complement-Associated DisordersALEXION PHARMACEUTICALSOct 4, 2023
EP3403646Liquid Pharmaceutical CompositionFRESENIUS KABI DEUTSCHLANDOct 5, 2022
EP3145488Liquid Pharmaceutical CompositionARES TRADINGApr 22, 2021
EP3145488Liquid Pharmaceutical CompositionARES TRADINGJul 22, 2020
EP3212667Pharmaceutical Anti-Tnf-Alpha Antibody FormulationRICHTER GEDEON NYRTDec 12, 2019
EP3212667Pharmaceutical Anti-Tnf-Alpha Antibody FormulationRICHTER GEDEON NYRTJun 19, 2019
EP3148510Liquid Pharmaceutical CompositionARES TRADINGMar 26, 2019

Latest patents of Samsung Bioepis opposed by its competitors

Explore Samsung Bioepis's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3036320Apr 3, 2024Control Of Protein Glycosylation By Culture Medium Supplementation And Cell Culture Process Parameters2
EP3122869Aug 10, 2022Methods For Overcoming Glutamine Deprivation During Mammalian Cell Culture1

Top competitors of Samsung Bioepis